Nexeon Medsystems Inc
OTC:NXNN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nexeon Medsystems Inc
OTC:NXNN
|
US |
|
Furukawa Co Ltd
TSE:5715
|
JP |
|
F
|
Forbidden Spirits Distilling Corp
XTSX:VDKA
|
CA |
|
Dyaco International Inc
TWSE:1598
|
TW |
|
U
|
Utron Ltd
TASE:UTRN
|
IL |
|
Ctp NV
AEX:CTPNV
|
NL |
|
I
|
IONOS Group SE
XETRA:IOS
|
DE |
|
ViewRay Inc
OTC:VRAYQ
|
US |
|
C
|
Cokyvina JSC
VN:CKV
|
VN |
|
S
|
Spire Inc
SWB:LGR
|
US |
|
Leonardo SpA
OTC:FINMF
|
IT |
|
Enensys Technologies SA
PAR:ALNN6
|
FR |
|
Calin Technology Co Ltd
TWSE:4976
|
TW |
Nexeon Medsystems Inc
Nexeon MedSystems, Inc. is a medical device company, which focuses on the development, manufacturing, and commercialization of neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. The company is headquartered in West Palm Beach, Florida. The company went IPO on 2017-08-01. The Company’s developing technology solutions device including electronics, software, mechanical engineering, and material science, as well as pharmaceuticals, protein chemistry, and cell biology. In addition, the Company is developing and commercializing NNS, an implantable neurostimulation and recording platform. The Company’s wholly-owned subsidiaries include Nexeon Medsystems Europe, SARL (Nexeon Europe), Nexeon Medsystems Puerto Rico Operating Company Corporation (NXPROC) and Pulsus Medical LLC.
Nexeon MedSystems, Inc. is a medical device company, which focuses on the development, manufacturing, and commercialization of neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. The company is headquartered in West Palm Beach, Florida. The company went IPO on 2017-08-01. The Company’s developing technology solutions device including electronics, software, mechanical engineering, and material science, as well as pharmaceuticals, protein chemistry, and cell biology. In addition, the Company is developing and commercializing NNS, an implantable neurostimulation and recording platform. The Company’s wholly-owned subsidiaries include Nexeon Medsystems Europe, SARL (Nexeon Europe), Nexeon Medsystems Puerto Rico Operating Company Corporation (NXPROC) and Pulsus Medical LLC.
